Which commonly prescribed drug is more effective for infants with epilepsy?
This is the question that a team of researchers from the Children’s Hospital of Chicago asked themselves. For more than 50% of infants diagnosed with epilepsy with no known cause, it is important that clinicians know which medication might be most likely to control the condition. Getting it right early would mean better future outcomes for these babies. So researchers from the Children’s Hospital of Chicago compared two of the most commonly prescribed drugs for infants with epilepsy whose epilepsy is not caused by a specific syndrome: levetiracetam and phenobarbital.
Their findings suggest that levetiracetam is more effective than phenobarbital. More detail of the research conducted at the Children’s Hospital of Chicago can be found here: